Day Wesley 4
4 · VIVUS INC · Filed Jan 29, 2013
Insider Transaction Report
Form 4
VIVUS INCVVUS
Day Wesley
VP, Clinical Research
Transactions
- Award
Incentive Stock Option (right to buy)
2013-01-25+8,100→ 8,100 totalExercise: $12.39Exp: 2023-01-25→ Common Stock (8,100 underlying) - Award
Non-Qualified Stock Option (right to buy)
2013-01-25+41,900→ 41,900 totalExercise: $12.39Exp: 2023-01-25→ Common Stock (41,900 underlying)
Holdings
- 1,052
Common Stock
Footnotes (2)
- [F1]Includes 1,052 shares acquired under the VIVUS, Inc. Employee Stock Purchase Plan on November 14, 2012.
- [F2]Twenty-five percent (25%) of the total number of shares become exercisable on 1/25/2014 and one forty-eighth (1/48th) of the total number of shares become exercisable on the 25th of each month thereafter.